153 related articles for article (PubMed ID: 16712424)
21. Semiautomated quantification of cytotoxic damage induced in cultured insect cells exposed to commercial Bacillus thuringiensis biopesticides.
Tayabali AF; Seligy VL
J Appl Toxicol; 1995; 15(5):365-73. PubMed ID: 8666719
[TBL] [Abstract][Full Text] [Related]
22. General Cytotoxicity Assessment by Means of the MTT Assay.
Tolosa L; Donato MT; Gómez-Lechón MJ
Methods Mol Biol; 2015; 1250():333-48. PubMed ID: 26272156
[TBL] [Abstract][Full Text] [Related]
23. Cellular toxicity of nanogenomedicine in MCF-7 cell line: MTT assay.
Ahmadian S; Barar J; Saei AA; Fakhree MA; Omidi Y
J Vis Exp; 2009 Apr; (26):. PubMed ID: 19352311
[TBL] [Abstract][Full Text] [Related]
24. Microplate assay for detection of bacterial contamination in tissue culture media.
Chakravortty D; Nanda Kumar KS
Indian J Exp Biol; 1997 Jan; 35(1):86-8. PubMed ID: 18345591
[TBL] [Abstract][Full Text] [Related]
25. Reduction of MTT by glutathione S-transferase.
York JL; Maddox LC; Zimniak P; McHugh TE; Grant DF
Biotechniques; 1998 Oct; 25(4):622-4, 626-8. PubMed ID: 9793644
[TBL] [Abstract][Full Text] [Related]
26. Analysis of Cell Viability by the MTT Assay.
Kumar P; Nagarajan A; Uchil PD
Cold Spring Harb Protoc; 2018 Jun; 2018(6):. PubMed ID: 29858338
[TBL] [Abstract][Full Text] [Related]
27. Current methodology of MTT assay in bacteria - A review.
Grela E; Kozłowska J; Grabowiecka A
Acta Histochem; 2018 May; 120(4):303-311. PubMed ID: 29606555
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of a soluble tetrazolium/formazan assay for cell growth and drug sensitivity in culture using human and other tumor cell lines.
Scudiero DA; Shoemaker RH; Paull KD; Monks A; Tierney S; Nofziger TH; Currens MJ; Seniff D; Boyd MR
Cancer Res; 1988 Sep; 48(17):4827-33. PubMed ID: 3409223
[TBL] [Abstract][Full Text] [Related]
29. Combining the rapid MTT formazan exocytosis assay and the MC65 protection assay led to the discovery of carbazole analogs as small molecule inhibitors of Abeta oligomer-induced cytotoxicity.
Hong HS; Maezawa I; Yao N; Xu B; Diaz-Avalos R; Rana S; Hua DH; Cheng RH; Lam KS; Jin LW
Brain Res; 2007 Jan; 1130(1):223-34. PubMed ID: 17157826
[TBL] [Abstract][Full Text] [Related]
30. Characterization of the cellular reduction of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT): subcellular localization, substrate dependence, and involvement of mitochondrial electron transport in MTT reduction.
Berridge MV; Tan AS
Arch Biochem Biophys; 1993 Jun; 303(2):474-82. PubMed ID: 8390225
[TBL] [Abstract][Full Text] [Related]
31. Both oxidative stress-dependent and independent effects of amyloid beta protein are detected by 3-(4,5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide (MTT) reduction assay.
Abe K; Saito H
Brain Res; 1999 May; 830(1):146-54. PubMed ID: 10350568
[TBL] [Abstract][Full Text] [Related]
32. Potential of a soluble tetrazolium/formazan assay for the evaluation of filarial viability.
Comley JC; Turner CH
Int J Parasitol; 1990 Apr; 20(2):251-5. PubMed ID: 2332282
[TBL] [Abstract][Full Text] [Related]
33. Development and validation of UPLC method for WST-1 cell viability assay and its application to MCTT HCE™ eye irritation test for colorful substances.
Joo KM; Kim S; Koo YJ; Lee M; Lee SH; Choi D; Lim KM
Toxicol In Vitro; 2019 Oct; 60():412-419. PubMed ID: 31247334
[TBL] [Abstract][Full Text] [Related]
34. Amyloid beta-peptide alters the distribution of early endosomes and inhibits phosphorylation of Akt in the presence of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT).
Kubo T; Nishimura S; Oda T
Brain Res Mol Brain Res; 2002 Oct; 106(1-2):94-100. PubMed ID: 12393269
[TBL] [Abstract][Full Text] [Related]
35. The MTT tetrazolium salt assay scrutinized: how to use this assay reliably to measure metabolic activity of cell cultures in vitro for the assessment of growth characteristics, IC50-values and cell survival.
Sieuwerts AM; Klijn JG; Peters HA; Foekens JA
Eur J Clin Chem Clin Biochem; 1995 Nov; 33(11):813-23. PubMed ID: 8620058
[TBL] [Abstract][Full Text] [Related]
36. Enhancement of MTT, a tetrazolium salt, exocytosis by amyloid beta-protein and chloroquine in cultured rat astrocytes.
Isobe I; Michikawa M; Yanagisawa K
Neurosci Lett; 1999 May; 266(2):129-32. PubMed ID: 10353344
[TBL] [Abstract][Full Text] [Related]
37. Inhibitors of V-type ATPases, bafilomycin A1 and concanamycin A, protect against beta-amyloid-mediated effects on 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) reduction.
Kane MD; Schwarz RD; St Pierre L; Watson MD; Emmerling MR; Boxer PA; Walker GK
J Neurochem; 1999 May; 72(5):1939-47. PubMed ID: 10217271
[TBL] [Abstract][Full Text] [Related]
38. Application of an MTT reduction assay for assessing sperm quality and predicting fertilising ability of domestic fowl semen.
Hazary RC; Chaudhuri D; Wishart GJ
Br Poult Sci; 2001 Mar; 42(1):115-7. PubMed ID: 11337959
[TBL] [Abstract][Full Text] [Related]
39. Microtiter plate assay for superoxide dismutase using MTT reduction by superoxide.
Madesh M; Balasubramanian KA
Indian J Biochem Biophys; 1998 Jun; 35(3):184-8. PubMed ID: 9803669
[TBL] [Abstract][Full Text] [Related]
40. Use of an aqueous soluble tetrazolium/formazan assay for cell growth assays in culture.
Cory AH; Owen TC; Barltrop JA; Cory JG
Cancer Commun; 1991 Jul; 3(7):207-12. PubMed ID: 1867954
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
